JANE STREET GROUP, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$8,803,220
-59.8%
545,091
+3.3%
0.00%
-57.1%
Q2 2023$21,901,708
+116.2%
527,752
+213.3%
0.01%
+75.0%
Q1 2023$10,131,364
+788.7%
168,463
+983.9%
0.00%
+300.0%
Q4 2022$1,140,079
+291.8%
15,543
+305.5%
0.00%
Q3 2022$291,000
-98.5%
3,833
-98.6%
0.00%
-100.0%
Q2 2022$19,211,000
+39.8%
276,418
+66.7%
0.01%
+60.0%
Q1 2022$13,739,000
-12.9%
165,829
-21.1%
0.01%0.0%
Q4 2021$15,773,000
-7.3%
210,075
+43.4%
0.01%
-16.7%
Q3 2021$17,021,000
-26.9%
146,516
+39.5%
0.01%
-33.3%
Q2 2021$23,300,000
+32.6%
105,041
-21.0%
0.01%0.0%
Q1 2021$17,573,000
-65.3%
132,943
-54.6%
0.01%
-65.4%
Q4 2020$50,665,000
+51.9%
292,797
-2.3%
0.03%
+30.0%
Q3 2020$33,357,000
+40.7%
299,688
-25.1%
0.02%
+17.6%
Q2 2020$23,715,000
+211.4%
399,905
+253.6%
0.02%
+142.9%
Q1 2020$7,616,000
-38.5%
113,100
-23.0%
0.01%
-58.8%
Q4 2019$12,378,000
-45.7%
146,897
-51.8%
0.02%
-54.1%
Q3 2019$22,776,000
+70.6%
304,583
+44.3%
0.04%
+54.2%
Q2 2019$13,350,000
+155.3%
211,142
+94.5%
0.02%
+166.7%
Q1 2019$5,230,000
+1083.3%
108,556
+721.6%
0.01%
+800.0%
Q4 2018$442,000
-3.9%
13,212
-41.9%
0.00%0.0%
Q4 2017$460,000
-85.2%
22,759
-85.4%
0.00%
-90.0%
Q3 2017$3,099,000
+17.8%
156,100
+2.7%
0.01%
+11.1%
Q2 2017$2,630,000152,0000.01%
Other shareholders
NOVOCURE LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders